KRAS and colorectal cancer: This cell line was selected for the screening phase of the project since it contains a spectrum of mutations typical of colorectal cancer, including APC, p53, KRAS and PIK3CA, and because this cell line is relatively radioresistant compared to other colorectal cancer cell lines such as HCT11623.